Updated:
Delos Capital Partners
We empower life sciences leaders to turn bold ideas into medical breakthroughs. | Delos Capital is a life sciences investment firm.
Delos Capital Partners
We empower life sciences leaders to turn bold ideas into medical breakthroughs. | Delos Capital is a life sciences investment firm. Our team draws upon diverse skills and a global network to support ground-breaking innovations that will improve lives around the world.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
United States
City
Cambridge
Corporate office
201 Broadway Suite 330, Cambridge, MA 02139, United States
Additional offices
Hong Kong
Sector focus
Frequently asked questions
What therapeutic areas does Delos Capital Partners target?
Delos's portfolio spans cardiometabolic disease, immunology, infectious disease, neurology, oncology, and rare disease. The firm also invests in medical devices and diagnostics. Its website tags each portfolio company by therapeutic area and product type.
Does Delos invest through fund commitments or solely through direct deals?
Delos deploys capital from its own multi-fund structure rather than committing as a limited partner to other managers. The firm runs three fund vintages — designated Fund I, Fund II, and Fund III on its portfolio page — and uses those pools to make direct equity and co-investments into life sciences companies.
How is Delos Capital Partners connected to Hong Kong?
Delos maintains a registered office at 19/F EC Healthcare Tower in Hong Kong's Central district, operating as Delos Advisors Limited. The dual-office structure in Cambridge and Hong Kong positions the firm to bridge life sciences opportunities between North American and Asian markets.
What investment stages does Delos Capital Partners typically target?
The firm operates across the full life sciences development spectrum. Its portfolio includes early-stage drug discovery platforms, clinical-stage therapeutic developers, and commercial-stage medical device companies, with holdings ranging from seed-stage biotechs to pre-IPO and public-to-private situations.
Who runs investment decisions at Delos Capital Partners?
The investment team is led by an unnamed founder and managing partner, supported by one partner, one managing director, and one associate. The website does not identify any of the investment professionals by name, which limits the ability to attribute sourcing or decision-making to specific individuals.
Does Delos Capital Partners maintain philanthropic structures?
No philanthropic foundation, donor-advised fund, or charitable vehicle affiliated with Delos Capital Partners has been publicly disclosed. The firm's website and available public records focus exclusively on its for-profit investment activities.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: